| Matched molecular pairs as a medicinal chemistry tool: miniperspective E Griffen, AG Leach, GR Robb, DJ Warner Journal of medicinal chemistry 54 (22), 7739-7750, 2011 | 282 | 2011 |
| Van der Waals interactions dominate ligand− protein association in a protein binding site occluded from solvent water E Barratt, RJ Bingham, DJ Warner, CA Laughton, SEV Phillips, ... Journal of the American Chemical Society 127 (33), 11827-11834, 2005 | 192 | 2005 |
| Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification DJ Warner, H Chen, LD Cantin, JG Kenna, S Stahl, CL Walker, T Noeske Drug Metabolism and Disposition 40 (12), 2332-2341, 2012 | 81 | 2012 |
| WizePairZ: a novel algorithm to identify, encode, and exploit matched molecular pairs with unspecified cores in medicinal chemistry DJ Warner, EJ Griffen, SA St-Gallay Journal of chemical information and modeling 50 (8), 1350-1357, 2010 | 80 | 2010 |
| Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD C De Savi, RJ Cox, DJ Warner, AR Cook, MR Dickinson, A McDonough, ... Journal of Medicinal Chemistry 57 (11), 4661-4676, 2014 | 32 | 2014 |
| Prospective prediction of antitarget activity by matched molecular pairs analysis DJ Warner, MH Bridgland‐Taylor, CE Sefton, DJ Wood Molecular Informatics 31 (5), 365-368, 2012 | 22 | 2012 |
| The discovery of new spirocyclic muscarinic M3 antagonists MJ Stocks, L Alcaraz, A Bailey, K Bowers, D Donald, H Edwards, F Hunt, ... Bioorganic & medicinal chemistry letters 20 (24), 7458-7461, 2010 | 20 | 2010 |
| Modelling the restoration of wild-type dynamic behaviour in ΔF508-CFTR NBD1 by 8-cyclopentyl-1, 3-dipropylxanthine DJ Warner, MM Vadolia, CA Laughton, ID Kerr, SW Doughty Journal of Molecular Graphics and Modelling 26 (3), 691-699, 2007 | 5 | 2007 |
| A monomeric form of INOS can rationalise observed SAR for inhibitors of dimerisation: quantum mechanics and docking compared AG Leach, LL Olsson, DJ Warner MedChemComm 4 (1), 180-186, 2013 | 4 | 2013 |
| Chemical Compounds 293 G Andrews, RJ Cox, C De Savi, P Meghani, HJ Sanganee, DJ Warner US Patent App. 12/471,599, 2010 | 4 | 2010 |
| Investigating the Conformational Preferences of Transforming Growth Factor-β Isoforms using Targeted Molecular Dynamics Simulations DJ Warner, IC Paterson, RB Sessions Journal of Chemical Theory and Computation 5 (3), 482-490, 2009 | 4 | 2009 |
| Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states G Andrews, RJ Cox, C De Savi, P Meghani, HJ Sanganee, DJ Warner | 2 | 2014 |
| derivados de fenoxipiridinilamida e seu uso no tratamento de estados de doenças mediados por pde4 G Andrews, RJ Cox, C de Savi, DJ Warner, P Meghani, HJ Sanganee | | 2021 |
| Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states pde4 G Andrews, RJ Cox, SC De, P Meghani, HJ Sanganee, DJ Warner | | 2015 |
| Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande P Meghani, G Andrews, RJ Cox, SC De, HJ Sanganee, DJ Warner | | 2014 |
| Derivados de fenoxipiridinilamida y su uso en el tratamiento de estados patológicos mediados por PDE4 G Andrews, RJ Cox, C De Savi, P Meghani, HJ Sanganee, DJ Warner | | 2014 |
| Phenoxypyridinylamide compounds G Andrews, RJ Cox, C De Savi, P Meghani, HJ Sanganee, DJ Warner US Patent 8,273,774, 2012 | | 2012 |
| Compuestos quimicos 293 G Andrews, RJ Cox, HJ Sanganee, DJ Warner, SC Da, P Meghani | | 2010 |
| Nuevos compuestos como inhibidores de pde4 A Glens, RJ Cox, HJ Sanganee, DJ Warner, C De Savi, M Premji | | 2010 |
| Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una … RJ Cox, G Andrews, HJ Sanganee, DJ Warner, SC De, P Meghani | | 2009 |
Ed GriffenMedChemica LtdDirección de correo verificada de medchemica.com
